Sort by
Refine Your Search
-
Category
-
Country
-
Employer
-
Field
-
, wearable sensor data, and behavioral measures. · Collect, process, and analyze multimodal datasets, including neural, physiological, and motion-tracking signals. · Develop and refine research protocols and
-
processes is highly beneficial. You are expected to have a keen interest in biomedical microsystems and the ability to interact with researchers in a very interdisciplinary environment. Excellent
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 12 days ago
indicate that centromere instability can lead to genome instability, inflammation, and senescence, including in non-cycling immune cells. In CenAGE, we propose a multi-layer synergistic approach to deliver a
-
19 Mar 2026 Job Information Organisation/Company Delft University of Technology (TU Delft) Research Field Engineering » Biomedical engineering Engineering » Computer engineering Researcher Profile
-
. General admission requirements are those defined in point 4. For the purpose of determining the appropriate profile for the activity to be developed, the following are special requirements: a) proven
-
of the contract. 4.1. General admission requirements are those defined in point 4. For the purpose of determining the appropriate profile for the activity to be developed, the following are special requirements: a
-
of the doctoral degree, under the terms of the applicable legislation. This formality must be completed by the signing date of the contract. 4.1. General admission requirements are those defined in point 4
-
be completed by the signing date of the contract. 4.1. General admission requirements are those defined in point 4. For the purpose of determining the appropriate profile for the activity to be
-
Requirements: Mandatory: PhD degree in Biomedical Sciences, Molecular Biology, Biochemistry or related areas with, at least, five years of postdoctoral experience ; Experience in the molecular biology of
-
, and have a mandate by the NIH to inform new therapies for this difficult-to-treat disease. Focus is on understanding how corrupt coding and non-coding (“dark genome”) genes that are part of